Literature DB >> 3296196

The efficacy of cardiovascular nuclear medicine exercise studies.

A Rozanski, D S Berman.   

Abstract

Radionuclide stress tests were initially introduced into medicine as new diagnostic tests for coronary artery disease (CAD). These tests are very effective for this purpose when applied to populations with an intermediate pre-test probability of coronary artery disease. Radionuclide stress tests, however, also are used now in guiding many management decisions in patients with established CAD, based on the ability of these tests to assess the extent and severity of myocardial ischemia, the functional significance of coronary stenoses, and myocardial viability. Specific uses beyond diagnosis include decisions regarding whom to catheterize, send to coronary bypass surgery, or angioplasty; risk stratification following myocardial infarction or before noncardiac surgery; and evaluation of the results of therapy. This article reviews both the diagnostic efficacy of radionuclide stress tests and their efficacy in guiding management decisions in patients with known coronary artery disease.

Entities:  

Mesh:

Year:  1987        PMID: 3296196     DOI: 10.1016/s0001-2998(87)80016-8

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  14 in total

1.  Investigation and management of stable angina: revised guidelines 1998. Joint Working Party of the British Cardiac Society and Royal College of Physicians of London.

Authors:  D de Bono
Journal:  Heart       Date:  1999-05       Impact factor: 5.994

2.  Effectiveness of (99m)Tc-tetrofosmin for assessment of heart functions in micropigs.

Authors:  Min Young Lee; Sang Hun Lee; Jae Hong Park; Jung Sun Heo; Yu Jin Lee; Han Na Suh; Jung Jun Min; Young Soon Seo; Ho Jae Han
Journal:  J Vet Sci       Date:  2007-09       Impact factor: 1.672

Review 3.  The role of nuclear medicine in clinical investigation.

Authors:  E M Prvulovich; J B Bomanji
Journal:  BMJ       Date:  1998-04-11

4.  Age and left ventricular ejection fraction identify patients with advanced breast cancer at high risk for development of epirubicin-induced heart failure.

Authors:  B Schaadt; H Kelbaek
Journal:  J Nucl Cardiol       Date:  1997 Nov-Dec       Impact factor: 5.952

Review 5.  Choosing a thallium-201 or technetium 99m sestamibi imaging protocol.

Authors:  J E Udelson
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

6.  Prospective diagnostic performance of semiconductor SPECT myocardial perfusion imaging: wall thickening analysis reduces the need for an additional prone acquisition.

Authors:  Loïc Djaileb; Benjamin Dubois; Nicolas de Leiris; Julien Leenhardt; Marjorie Canu; Olivier Phan Sy; Adrien Carabelli; Bastien Boussat; Laurent Dumas; Alexis Broisat; Gérald Vanzetto; Daniel Fagret; Catherine Ghezzi; Gilles Barone-Rochette; Laurent M Riou
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-18       Impact factor: 9.236

Review 7.  Stress testing. Directions for the future.

Authors:  C Foster
Journal:  Sports Med       Date:  1988-07       Impact factor: 11.136

8.  Comparative accuracy of supine-only and combined supine-prone myocardial perfusion imaging in men.

Authors:  Vicente Taasan; Anita Wokhlu; Michael V Taasan; Raman S Dusaj; Ajay Mehta; Steven Kraft; David Winchester; David Wymer
Journal:  J Nucl Cardiol       Date:  2015-12-30       Impact factor: 5.952

9.  Diagnostic accuracy of gated Tc-99m sestamibi stress myocardial perfusion SPECT with combined supine and prone acquisitions to detect coronary artery disease in obese and nonobese patients.

Authors:  Daniel S Berman; Xingping Kang; Hidetaka Nishina; Piotr J Slomka; Leslee J Shaw; Sean W Hayes; Ishac Cohen; John D Friedman; James Gerlach; Guido Germano
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

10.  Use of coronary calcium scanning for predicting inducible myocardial ischemia: Influence of patients' clinical presentation.

Authors:  Alan Rozanski; Heidi Gransar; Nathan D Wong; Leslee J Shaw; Romalisa Miranda-Peats; Sean W Hayes; John D Friedman; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2007 Sep-Oct       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.